BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 36497169)

  • 21. The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis.
    Burt RK; Patel D; Thomas J; Yeager A; Traynor A; Heipe F; Arnold R; Marmont A; Collier D; Glatstein E; Snowden J
    Bone Marrow Transplant; 2004 Nov; 34(9):745-51. PubMed ID: 15361910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis.
    Shouval R; Furie N; Raanani P; Nagler A; Gafter-Gvili A
    Biol Blood Marrow Transplant; 2018 May; 24(5):937-944. PubMed ID: 29374527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulatory therapy for SSc: will high-intensity immunosuppression with stem cell rescue improve outcome?
    Crofford LJ
    Curr Rheumatol Rep; 2005 Apr; 7(2):142-9. PubMed ID: 15760594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autologous hematopoietic stem cell transplantation for systemic sclerosis : Position statement of the stem cell therapy working party of the German Society of Rheumatology].
    Alexander T; Henes J; Distler JHW; Schmalzing M; Blank N; Kötter I; Hiepe F
    Z Rheumatol; 2020 Jun; 79(5):429-436. PubMed ID: 32322977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.
    Nash RA; McSweeney PA; Crofford LJ; Abidi M; Chen CS; Godwin JD; Gooley TA; Holmberg L; Henstorf G; LeMaistre CF; Mayes MD; McDonagh KT; McLaughlin B; Molitor JA; Nelson JL; Shulman H; Storb R; Viganego F; Wener MH; Seibold JR; Sullivan KM; Furst DE
    Blood; 2007 Aug; 110(4):1388-96. PubMed ID: 17452515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous hematopoietic stem cell transplantation for autoimmune disease--is it now ready for prime time?
    Atkins HL; Muraro PA; van Laar JM; Pavletic SZ
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S177-83. PubMed ID: 22226104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Esophageal motility in systemic sclerosis before and after autologous hematopoietic cell transplantation.
    Woo MMK; Levin D; Li DY; David J; Buresi M; Gupta M; Nasser Y; Andrews CN; Durand C; Osman MS; Jamani K; Weatherald J; Johannson KA; Howlett JG; Hemmati I; Kim H; Curley M; Storek J
    Clin Rheumatol; 2023 Dec; 42(12):3267-3274. PubMed ID: 37702810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation.
    Servaas NH; Spierings J; Pandit A; van Laar JM
    Clin Exp Immunol; 2020 Jul; 201(1):34-39. PubMed ID: 31990046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of Life.
    Maltez N; Puyade M; Wang M; Lansiaux P; Marjanovic Z; Charles C; Steele R; Baron M; Colmegna I; Hudson M; Farge D;
    Arthritis Rheumatol; 2021 Feb; 73(2):305-314. PubMed ID: 32909693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular Therapies in Systemic Sclerosis: Recent Progress.
    van Rhijn-Brouwer FC; Gremmels H; Fledderus JO; Radstake TR; Verhaar MC; van Laar JM
    Curr Rheumatol Rep; 2016 Feb; 18(2):12. PubMed ID: 26943351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registry.
    Blank N; Schmalzing M; Moinzadeh P; Oberste M; Siegert E; Müller-Ladner U; Riemekasten G; Günther C; Kötter I; Zeidler G; Pfeiffer C; Juche A; Jandova I; Ehrchen J; Susok L; Schmeiser T; Sunderkötter C; Distler JHW; Worm M; Kreuter A; Keyßer G; Lorenz HM; Krieg T; Hunzelmann N; Henes J;
    Arthritis Res Ther; 2022 Nov; 24(1):258. PubMed ID: 36424638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on stem cell transplantation for systemic sclerosis: recent trial results.
    Naraghi K; van Laar JM
    Curr Rheumatol Rep; 2013 May; 15(5):326. PubMed ID: 23516015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
    Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
    Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners.
    Farge D; Burt RK; Oliveira MC; Mousseaux E; Rovira M; Marjanovic Z; de Vries-Bouwstra J; Del Papa N; Saccardi R; Shah SJ; Lee DC; Denton C; Alexander T; Kiely DG; Snowden JA
    Bone Marrow Transplant; 2017 Nov; 52(11):1495-1503. PubMed ID: 28530671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular therapy of systemic sclerosis.
    van Laar JM; Tyndall A
    Curr Rheumatol Rep; 2008 Jul; 10(3):189-94. PubMed ID: 18638426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis.
    Helbig G; Widuchowska M; Koclęga A; Kopińska A; Kopeć-Mędrek M; Gaweł WB; Spałek A; Żak J; Grygoruk-Wiśniowska I; Liwoch R; Kucharz E; Markiewicz M
    Clin Rheumatol; 2018 Jun; 37(6):1709-1714. PubMed ID: 29256111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches.
    Xue E; Minniti A; Alexander T; Del Papa N; Greco R; On Behalf Of The Autoimmune Diseases Working Party Adwp Of The European Society For Blood And Marrow Transplantation Ebmt
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overlapping Case of Advanced Systemic Sclerosis and IgG4-Related Disease after Autologous Hematopoietic Stem Cell Transplantation.
    Dulko AJ; Butrimiene I; Cypiene A; Peceliunas V; Petroska D; Stankeviciene E; Rugiene R
    Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives.
    Di Benedetto P; Ruscitti P; Cipriani P; Giacomelli R
    Autoimmun Rev; 2020 Nov; 19(11):102662. PubMed ID: 32942028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modern drug therapy for systemic sclerosis associated interstitial lung disease].
    Aringer M; Koschel D; Krause A; Schneider U; Gläser S
    Dtsch Med Wochenschr; 2022 Feb; 147(4):179-186. PubMed ID: 34861699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.